by Marilyn T. McGoldrick, Esq. Takeda Pharmaceuticals executives have reportedly offered more than $2.3 billion dollars to resolve the more than 8,000 lawsuits alleging that it hid the bladder cancer risks of its popular diabetes drug Actos. The settlement must still be approved, but reportedly the details of the settlement are final. If you or a… Read More


By Marilyn T. McGoldrick, Esq. Posted on Nov 3, 2014 A global settlement valued at over $1 billion dollars with the manufacturer of the Stryker Rejuvenate and ABG II hip implants, Homedica Osteonics Corp. (also known as Stryker Orthopaedics), has been announced after a hearing today before the judge overseeing the Stryker MultiDistrict Litigation. Patients who underwent… Read More


By David C. Strouss, Esq. Posted on Sep 26, 2014 Thornton Law Firm and co-counsel recently settled a lawsuit on behalf of a child with serious birth defects whose mother was exposed to toxic substances during pregnancy while working in the semiconductor chip manufacturing industry. The settlement was reached just before trial was scheduled to… Read More


Biomet, Inc. and counsel for Plaintiffs reached an agreement to settle all cases currently pending in the Biomet MDL (In Re Biomet M2A Magnum Hip Implant Products Liability Litigation, MDL 2391) and any future cases filed on or before April 15, 2014. To be eligible for compensation a plaintiff must have been implanted with a Biomet M2a 38 or M2A Magnum hip replacement system and underwent surgery to revise the device more than 180 days after it was implanted.… Read More